tiprankstipranks

Syntone Ventures LLC Insider Profile

4 Followers
Syntone Ventures LLC, Ten Percent Owner at Outlook Therapeutics, holds 1.71M shares in Outlook Therapeutics (Ticker: OTLK).
tipranks
Syntone Ventures LLC

Syntone Ventures LLC
Outlook Therapeutics (OTLK)
Ten Percent Owner

Ranked #37,637 out of 98,501 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+24.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
100.00%
A breakdown of Syntone Ventures LLC's holdings

Insider Roles

Outlook Therapeutics
(OTLK)
Ten Percent Owner
Roles that Syntone Ventures LLC holds in companies

Most Profitable Insider Trade

Stock:
Outlook Therapeutics
(OTLK)
Rating:Informative Buy
Date:Jul 28, 2020 - Jul 28, 2021
Return:+76.10%
The most profitable trade made by Syntone Ventures LLC

Syntone Ventures LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Outlook Therapeutics
Apr 17, 2024
Ten Percent Owner
Uninformative Buy
$14.14M
Success Rate for
OTLK
1 out of 2 profitable transactions on
OTLK
50%
Average Return for
OTLK
Average return per transaction on
OTLK
+24.95%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 28, 2020
Informative Buy
$995.88K
-
$1.21
+76.10%
Feb 04, 2021
Informative Buy
$3.00M
-
$1.00
-26.20%
Apr 17, 2024
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Syntone Ventures LLC's performance on stock

Syntone Ventures LLC insider profile FAQ

What is the percentage of profitable transactions made by Syntone Ventures LLC?
The percentage of profitable transactions made by Syntone Ventures LLC is 50%.
    What is the average return per transaction made by Syntone Ventures LLC?
    The average return per transaction made by Syntone Ventures LLC is 24.90%.
      What stocks does Syntone Ventures LLC hold?
      Syntone Ventures LLC holds: OTLK stocks.
        What was Syntone Ventures LLC’s latest transaction?
        Syntone Ventures LLC latest transaction was an Uninformative Buy of ―.
          What was Syntone Ventures LLC's most profitable transaction?
          Syntone Ventures LLC’s most profitable transaction was an Informative Buy of OTLK stock on July 28, 2020. The return on the trade was 76.10%.
            What is Syntone Ventures LLC's role in Outlook Therapeutics?
            Syntone Ventures LLC's role in Outlook Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.